KP-100LI

· Kringle Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KP-100LI, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar [Phase 3]